Ledger.Open graph →
SEC Form D · filed March 9, 2017

NEOPHARM PHARMACANN INVESTORS II, LLC

Offering
$20.0M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Investing
Location
CHICAGO, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

John P. Wagner · Chicago, ILExecJames Flanigan, Jr · Chicago, ILExecBrad Leshnock · Oak Park, ILExecJoseph Flanagan · CHICAGO, ILExecJoseph Flanagan · Irvine, CAExecBrad Leshnock · Oak Park, ILExecFaith Kosobucki · Durham, NCExecJohn P. Wagner · Chicago, ILExecJames Flanigan, Jr · Chicago, ILExecJames P. Barry · Chicago, ILExecBarbara L. Burns · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗